Galectin Therapeutics GALT
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 4.16 | 94.50 | -0.08 | -3,365 | -6 | |
| 2025Q3 | 4.24 | 65.96 | -0.13 | -4,198 | -8 | |
| 2025Q2 | 2.11 | 81.21 | -0.12 | -4,625 | -8 | |
| 2025Q1 | 1.22 | 100.13 | -0.15 | -7,897 | -10 | |
| 2024Q4 | 1.29 | 121.34 | -0.19 | -12,428 | -12 | |
| 2024Q3 | 2.75 | 93.21 | -0.18 | -9,066 | -11 | |
| 2024Q2 | 2.26 | 101.70 | -0.20 | -11,291 | -12 | |
| 2024Q1 | 2.39 | 92.44 | -0.19 | -9,648 | -11 | |
| 2023Q4 | 1.66 | 104.49 | -0.16 | -9,561 | -10 | |
| 2023Q3 | 1.92 | 95.55 | -0.23 | -9,166 | -10 | |
| 2023Q2 | 1.44 | 106.37 | -0.16 | -9,003 | -9 | |
| 2023Q1 | 2.10 | 93.45 | -0.19 | -10,342 | -12 | |
| 2022Q4 | 1.13 | 102.97 | -0.18 | -10,633 | -11 | |
| 2022Q3 | 1.63 | 97.53 | -0.14 | -8,122 | -9 | |
| 2022Q2 | 1.31 | 102.96 | -0.16 | -9,662 | -10 | |
| 2022Q1 | 1.61 | 102.37 | -0.17 | -9,935 | -10 | |
| 2021Q4 | 2.07 | 106.85 | -0.12 | -7,425 | -7 | |
| 2021Q3 | 3.88 | 98.04 | -0.14 | -8,244 | -9 | |
| 2021Q2 | 3.20 | 97.96 | -0.15 | -8,193 | -8 | |
| 2021Q1 | 2.17 | 100.02 | -0.11 | -6,317 | -6 |